C3G forms complexes with Bcr-Abl and p38α MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion

被引:25
|
作者
Maia, Vera [1 ]
Ortiz-Rivero, Sara [1 ,3 ]
Sanz, Maria [1 ]
Gutierrez-Berzal, Javier [1 ]
Alvarez-Fernandez, Indira [1 ]
Gutierrez-Herrero, Sara [1 ,3 ]
Maria de Pereda, Jose [1 ]
Porras, Almudena [2 ]
Guerrero, Carmen [1 ,3 ]
机构
[1] Univ Salamanca, CSIC, IBMCC, Ctr Invest Canc, E-37008 Salamanca, Spain
[2] UCM, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Fac Farm, Dept Bioquim & Biol Mol 2, Madrid, Spain
[3] Univ Salamanca, Fac Med, Dept Med, Inst Invest Biomed Salamanca IBSAL, E-37008 Salamanca, Spain
来源
关键词
C3G; p38 alpha MAPK; Cbl; p130Cas; Abi1; Bcr-Abl; CML; Cell adhesion; NUCLEOTIDE-EXCHANGE FACTOR; CHRONIC MYELOGENOUS LEUKEMIA; ADAPTER PROTEIN CRKL; UNDERLYING ABNORMAL TRAFFICKING; TYROSINE KINASE-ACTIVITY; ACTIN-BINDING DOMAIN; SH3; DOMAIN; MALIGNANT PROGENITORS; TRANSFORMING ACTIVITY; HEMATOPOIETIC-CELLS;
D O I
10.1186/1478-811X-11-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Previous studies by our group and others have shown that C3G interacts with Bcr-Abl through its SH3-b domain. Results: In this work we show that C3G and Bcr-Abl form complexes with the focal adhesion (FA) proteins CrkL, p130Cas, Cbl and Abi1 through SH3/SH3-b interactions. The association between C3G and Bcr-Abl decreased upon Abi1 or p130Cas knock-down in K562 cells, which suggests that Abi1 and p130Cas are essential partners in this interaction. On the other hand, C3G, Abi1 or Cbl knock-down impaired adhesion to fibronectin, while p130Cas silencing enhanced it. C3G, Cbl and p130Cas-SH3-b domains interact directly with common proteins involved in the regulation of cell adhesion and migration. Immunoprecipitation and immunofluorescence studies revealed that C3G form complexes with the FA proteins paxillin and FAK and their phosphorylated forms. Additionally, C3G, Abi1, Cbl and p130Cas regulate the expression and phosphorylation of paxillin and FAK. p38 alpha MAPK also participates in the regulation of adhesion in chronic myeloid leukemia cells. It interacts with C3G, CrkL, FAK and paxillin and regulates the expression of paxillin, CrkL and a5 integrin, as well as paxillin phosphorylation. Moreover, double knock-down of C3G/p38 alpha decreased adhesion to fibronectin, similarly to the single silencing of one of these genes, either C3G or p38 alpha. These suggest that C3G and p38 alpha MAPK are acting through a common pathway to regulate cell adhesion in K562 cells, as previously described for the regulation of apoptosis. Conclusions: Our results indicate that C3G-p38 alpha MAPK pathway regulates K562 cell adhesion through the interaction with FA proteins and Bcr-Abl, modulating the formation of different protein complexes at FA.
引用
收藏
页数:17
相关论文
共 14 条
  • [1] C3G forms complexes with Bcr-Abl and p38α MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion
    Vera Maia
    Sara Ortiz-Rivero
    María Sanz
    Javier Gutierrez-Berzal
    Indira Álvarez-Fernández
    Sara Gutierrez-Herrero
    Jose María de Pereda
    Almudena Porras
    Carmen Guerrero
    Cell Communication and Signaling, 11
  • [2] Perturbation of p38α MAPK as a Novel Strategy to Effectively Sensitize Chronic Myeloid Leukemia Cells to Therapeutic BCR-ABL Inhibitors
    Kuo, Yi-Hue
    Wei, Shih-Hsiang
    Jiang, Jie-Hau
    Chang, Yueh-Shih
    Liu, Mei-Yin
    Fu, Shu-Ling
    Huang, Chi-Ying F.
    Lin, Wey-Jinq
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [3] Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl
    Gutiérrez-Berzal, J
    Castellano, E
    Martin-Encabo, S
    Gutiérrez-Cianca, N
    Hernández, JM
    Santos, E
    Guerrero, C
    EXPERIMENTAL CELL RESEARCH, 2006, 312 (06) : 938 - 948
  • [4] C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells
    de Jong, R
    van Wijk, A
    Heisterkamp, N
    Groffen, J
    ONCOGENE, 1998, 17 (21) : 2805 - 2810
  • [5] C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells
    Ron de Jong
    Arnoud van Wijk
    Nora Heisterkamp
    John Groffen
    Oncogene, 1998, 17 : 2805 - 2810
  • [6] Regulation of fibulin-3 expression by C3G/p38alpha MAPK cascade in normal and tumour cells
    Arechederra, M.
    Priego, N.
    Vazquez-Carballo, A.
    Gutierrez-Uzquiza, A.
    Guierrez-Herrero, S.
    Guerrero, C.
    Porras, A.
    FEBS JOURNAL, 2012, 279 : 146 - 146
  • [7] Chlorogenic acid-inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells
    Bandyopadhyay, G
    Biswas, T
    Roy, KC
    Mandal, S
    Mandal, C
    Pal, BC
    Bhattacharya, S
    Rakshit, S
    Bhattacharya, DK
    Chaudhuri, U
    Konar, A
    Bandyopadhyay, S
    BLOOD, 2004, 104 (08) : 2514 - 2522
  • [8] C3G down-regulates p38 MAPK activity in response to stress by Rap-1 independent mechanisms: Involvement in cell death
    Gutierrez-Uzquiza, Alvaro
    Arechederra, Maria
    Molina, Isabel
    Banos, Rocio
    Maia, Vera
    Benito, Manuel
    Guerrero, Carmen
    Porras, Almudena
    CELLULAR SIGNALLING, 2010, 22 (03) : 533 - 542
  • [9] Blood stem cell mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: Quantification of BCR-ABL positive cells by interphase FISH and competitive polymerase chain reaction.
    Keil, F
    Mitterbauer, G
    Chen, X
    Haas, OA
    Kalhs, P
    Lechner, K
    Mannhalter, C
    Moser, KR
    Louda, N
    Worel, N
    Pirc-Danoewinata, H
    Rabitsch, W
    Loidolt, H
    Greinix, HT
    BLOOD, 1999, 94 (10) : 339B - 339B
  • [10] The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines
    Xu, YX
    Voelter-Mahlknecht, S
    Mahlknecht, U
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 15 (01) : 169 - 172